Nomura Holdings Inc Biotechnology

Nomura Holdings Inc

  • $47 Billion
  • Q1 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
NVO
Novo Nordisk A S
PUT
$48.6 Million
700K
Q1 2025
Added 32.76%
BMRN
Biomarin Pharmaceutical Inc
CALL
$20.4 Million
288K
Q1 2025
Reduced 27.16%
VRTX
Vertex Pharmaceuticals Inc
PUT
$13.6 Million
28K
Q1 2025
Reduced 89.69%
VRTX
Vertex Pharmaceuticals Inc
CALL
$13.6 Million
28K
Q1 2025
Reduced 89.69%
SRPT
Sarepta Therapeutics, Inc.
CALL
$5.81 Million
91.1K
Q1 2025
Reduced 34.64%
BBIO
Bridge Bio Pharma, Inc.
CALL
$5.48 Million
159K
Q1 2025
Added 12.46%
EXEL
Exelixis, Inc.
CALL
$5.21 Million
141K
Q4 2024
Added 141.88%
UTHR
United Therapeutics Corp
CALL
$4.62 Million
15K
Q1 2025
Reduced 26.86%
UTHR
United Therapeutics Corp
PUT
$4.62 Million
15K
Q1 2025
Reduced 26.86%
EXEL
Exelixis, Inc.
PUT
$3.19 Million
86.3K
Q4 2024
Added 141.88%
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$3.17 Million
5K
Q1 2025
Reduced 65.36%
BBIO
Bridge Bio Pharma, Inc.
PUT
$2.9 Million
84K
Q1 2025
Added 12.46%
KRYS
Krystal Biotech, Inc.
CALL
$2.52 Million
14K N/A
KRYS
Krystal Biotech, Inc.
PUT
$2.52 Million
14K N/A
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$2.43 Million
9K
Q3 2024
Added 177.76%
CORT
Corcept Therapeutics Inc
PUT
$2.34 Million
20.5K
Q1 2025
New holding
CYTK
Cytokinetics Inc
CALL
$2.31 Million
57.5K
Q1 2025
Reduced 56.63%
SRPT
Sarepta Therapeutics, Inc.
PUT
$2.2 Million
34.4K
Q1 2025
Reduced 34.64%
AXSM
Axsome Therapeutics, Inc.
PUT
$2.04 Million
17.5K
Q4 2024
Reduced 72.11%
AXSM
Axsome Therapeutics, Inc.
CALL
$2.04 Million
17.5K
Q4 2024
Reduced 72.11%
RYTM
Rhythm Pharmaceuticals, Inc.
CALL
$1.83 Million
34.5K N/A
RARE
Ultragenyx Pharmaceutical Inc.
CALL
$1.22 Million
33.8K
Q1 2023
Added 44.38%
CYTK
Cytokinetics Inc
PUT
$1.15 Million
28.7K
Q1 2025
Reduced 56.63%
CRSP
Crispr Therapeutics Ag
CALL
$1.02 Million
30K
Q1 2025
New holding
CRSP
Crispr Therapeutics Ag
PUT
$1.02 Million
30K
Q1 2025
New holding
TVTX
Travere Therapeutics, Inc.
CALL
$1 Million
56K N/A
NVO
Novo Nordisk A S
CALL
$680,000
9.8K
Q1 2025
Added 32.76%
IONS
Ionis Pharmaceuticals Inc
CALL
$603,000
20K
Q1 2025
Reduced 33.82%
MIRM
Mirum Pharmaceuticals, Inc.
CALL
$567,000
12.6K N/A
ARVN
Arvinas, Inc.
CALL
$491,000
70K
Q3 2024
New holding
FOLD
Amicus Therapeutics, Inc.
PUT
$408,000
50K
Q1 2025
New holding
FOLD
Amicus Therapeutics, Inc.
CALL
$408,000
50K
Q1 2025
New holding
ABUS
Arbutus Biopharma Corp
PUT
$349,000
100K N/A
ABUS
Arbutus Biopharma Corp
CALL
$349,000
100K N/A
ARWR
Arrowhead Pharmaceuticals, Inc.
CALL
$343,000
27K
Q1 2025
Reduced 31.41%
ARWR
Arrowhead Pharmaceuticals, Inc.
PUT
$343,000
27K
Q1 2025
Reduced 31.41%
NVAX
Novavax Inc
PUT
$333,000
52K
Q1 2025
New holding
SNDX
Syndax Pharmaceuticals Inc
PUT
$331,000
27K
Q3 2024
New holding
SNDX
Syndax Pharmaceuticals Inc
CALL
$331,000
27K
Q3 2024
New holding
NTLA
Intellia Therapeutics, Inc.
PUT
$284,000
40K
Q1 2024
New holding
NTLA
Intellia Therapeutics, Inc.
CALL
$284,000
40K
Q1 2024
New holding
VIR
Vir Biotechnology, Inc.
PUT
$259,000
40K N/A
VIR
Vir Biotechnology, Inc.
CALL
$259,000
40K N/A
CAPR
Capricor Therapeutics, Inc.
CALL
$231,000
24.4K N/A
CMPX
Compass Therapeutics, Inc.
PUT
$186,000
98K
Q1 2025
New holding
QURE
Uni Qure N.V.
CALL
$159,000
15K
Q1 2025
New holding
Filter Shares Options
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email